EMILY JOHNSTON: Open Payments
NPI 1053794263 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 22 payments from 13 companies in 2025. Trend: 2023 $809 · 2024 $488 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $154 |
| Calliditas Therapeutics US Inc. | 3 | $59 |
| Travere Therapeutics, Inc. | 4 | $41 |
| ANI Pharmaceuticals, Inc. | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| NxStage Medical, Inc. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $15 |
Products named: TAVNEOS, TARPEYO, KRYSTEXXA, PURIFIED CORTROPHIN GEL, Kerendia, INJECTAFER, Empaveli, TERLIVAZ.
Industry payments across MO — which companies pay providers there.
